TRYTON Side Branch StentBuilt for bifurcation
• Simplify treatment
• Superior procedural and device success*
• Predictable outcomes
Only FDA Approved & CE Marked Bifurcated Stent
The internet site you have requested is intended for the residents of a particular country or countries where the product is currently commercially available. As a result, the site may contain information on the Tryton Side Branch Stent or uses of the stent that are not approved in other countries or regions. If you are a resident of a country other than those to which the site is directed, please contact your local Tryton Medical representative or the company headquarters to obtain appropriate product information for your country of residence.
*As compared to a provisional stenting strategy. Genereux et al. Catheterization and Cardiovascular Interventions. 2016; 87:1231-41. This study was not designed to demonstrate statistical differences in procedural or device success.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician. For healthcare professionals only. Prior to use, refer to the instruction for use supplied with this device for indications, contraindications, side effects, suggested procedure, warnings and precautions. WARNINGS: Use of the Tryton Side Branch Stent in appropriately sized main vessels and side branches is required for safe and effective performance of the device. Do not use the Tryton Stent in small side branches [<2.50 mm in diameter by visual assessment or <2.25 mm in diameter by quantitative coronary angiography (QCA)], as its use may lead to an increased risk of adverse cardiac events such as myocardial infarction and the need for repeat revascularization. To confirm appropriately-sized side branch diameters, the diameter of the pre-dilation balloon inflated to nominal pressure may be used as a reference. Alternatively, the use of quantitative imaging methods such as on-line quantitative coronary angiography, intravascular ultrasound or optimal coherence tomography should be considered. Use of the Tryton Side Branch Stent, as with percutaneous coronary stent implantation procedures in general, is known to be associated with the following risks: Vessel thrombosis. Increased length of hospital stay relative to those of coronary balloon angioplasty alone. Judicious selection of patients to receive this device rather than balloon angioplasty alone is strongly advised. infection secondary to contamination of the stent may lead to thrombosis, pseudoaneurysm or rupture. The stent may cause spasm, distal embolization, thrombus, or could migrate from the site of implantation. Excessive dilatation of the artery may cause vessel rupture and life-threatening bleeding. Stents may not be fully expanded during deployment, particularly in resistant lesions. Stent dislodgment from the balloon surface during deployment and/or dislodgment from the target site post-deployment can occur. Major bleeding.